Description | Pegaldesleukin, a conjugate of polyethylene glycol and interleukin-2 (PEG-IL2), exhibits antiviral activity with potential applications in managing HIV. It may delay the progression of HIV infection by preserving the immune repertoire [1] [2] [3]. |
molecular weight | N/A |
CAS | 141752-91-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |